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Background
HIV resistance to the integrase inhibitor raltegravir (RAL)
in treated patients is characterized by three main distinct
resistance pathways, for which the primary mutations are:
N155H, Q148H/K/R, or Y143R/H/C. These genotypes
may emerge sequentially, always carried by distinct viral
genomes. The mechanism explaining the sequential emer-
gence and in vivo dynamics along with viral escape from
RAL treatment are poorly understood. We hypothesize
that differences in the in vivo dynamics of HIV resistance
to RAL, which must be a direct consequence of the
phenotypic expression of viral resistance and/or of viral
fitness, are due to the genetic context of the integrase
carried by viral variants infecting individual patient.
Materials and methods
We selected four patients infected with subtype-B HIV
and for whom different prototypic evolutionary profiles of
resistance to RAL were observed. Replication competent
HIV molecular clones were constructed, which carried the
integrase alleles from the dominant pre-therapy viral
variants. Different primary resistance mutations were then
introduced by site directed mutagenesis in the pre-therapy
integrase sequences. We measured the impact of the
genetic context of integrase on the phenotypic expression
of resistance mutations by comparing baseline and
mutated clones for viral fitness and resistance.
Results
In 2 patients, mutation N155H emerged and persisted for
several months (7 and 22, respectively) until treatment
was changed. In 2 other patients Q148H emerged as the
first detectable mutation or after a brief appearance
of N155H.
Insertion of the mutation N155H had a moderate
impact on virus fitness (residual fitness 40-60%) and
induced a significant increase in resistance to RAL (15 to
60-fold) in all integrase contexts. In contrast, the impact of
mutation Q148H differed substantially depending on the
integrase allele in which it was inserted. In particular, it
dramatically reduced the infectivity of one virus issued
from a patient in whom this mutation did not emerge
during RAL treatment. On the other hand, it preserved
infectivity and it conferred high-level resistance in the
context of the virus in which it rapidly emerged in vivo.
Conclusions
Evolution toward different resistance genotypes is largely
determined by the capacity of different integrase alleles
present at baseline to minimize the effect of mutations on
virus fitness, while allowing expression of resistance.
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